US hospital alliance appoints CEO to in-house drugmaking business
A number of US hospitals are pressing ahead with plans to launch their own generics company, Civica Rx, with the appointment of Martin VanTrieste as chief executive.
In January 2018, five organizations, representing over 450 hospitals, joined forces to launch the company with the objective of “helping patients by addressing the often unwarranted shortages and high costs of lifesaving generic medications."
Mr VanTrieste, who will not take a salary for his efforts, has been persuaded to come out of retirement to head up the company. He was formerly chief quality officer at Amgen (Nasdaq: AMGN), and has also worked at Abbott (NYSE: ABT) and Bayer (BAYN: DE) in the area of sterile injectable drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze